BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38084984)

  • 1. Effectiveness of Prophylactic Oral and/or Vaginal Probiotic Supplementation in the Prevention of Recurrent Urinary Tract Infections: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Gupta V; Mastromarino P; Garg R
    Clin Infect Dis; 2024 May; 78(5):1154-1161. PubMed ID: 38084984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection.
    Stapleton AE; Au-Yeung M; Hooton TM; Fredricks DN; Roberts PL; Czaja CA; Yarova-Yarovaya Y; Fiedler T; Cox M; Stamm WE
    Clin Infect Dis; 2011 May; 52(10):1212-7. PubMed ID: 21498386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Probiotic Prophylaxis After The First Febrile Urinary Tract Infection in Children With Normal Urinary Tracts.
    Sadeghi-Bojd S; Naghshizadian R; Mazaheri M; Ghane Sharbaf F; Assadi F
    J Pediatric Infect Dis Soc; 2020 Jul; 9(3):305-310. PubMed ID: 31100124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics for preventing urinary tract infections in adults and children.
    Schwenger EM; Tejani AM; Loewen PS
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD008772. PubMed ID: 26695595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactobacillus rhamnosus PL1 and Lactobacillus plantarum PM1 versus placebo as a prophylaxis for recurrence urinary tract infections in children: a study protocol for a randomised controlled trial.
    Daniel M; Szymanik-Grzelak H; Turczyn A; Pańczyk-Tomaszewska M
    BMC Urol; 2020 Oct; 20(1):168. PubMed ID: 33097017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a study protocol for a randomised controlled trial.
    Lee BB; Toh SL; Ryan S; Simpson JM; Clezy K; Bossa L; Rice SA; Marial O; Weber G; Kaur J; Boswell-Ruys C; Goodall S; Middleton J; Tudehope M; Kotsiou G
    BMC Urol; 2016 Apr; 16():18. PubMed ID: 27084704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent urinary tract infections in women: How promising is the use of probiotics?
    Gupta V; Nag D; Garg P
    Indian J Med Microbiol; 2017; 35(3):347-354. PubMed ID: 29063878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial.
    Heczko PB; Tomusiak A; Adamski P; Jakimiuk AJ; Stefański G; Mikołajczyk-Cichońska A; Suda-Szczurek M; Strus M
    BMC Womens Health; 2015 Dec; 15():115. PubMed ID: 26635090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of an oral probiotic containing lactobacillus, bifidobacterium, and bacillus species on the vaginal microbiota of spayed female dogs.
    Hutchins RG; Bailey CS; Jacob ME; Harris TL; Wood MW; Saker KE; Vaden SL
    J Vet Intern Med; 2013; 27(6):1368-71. PubMed ID: 24033665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women.
    Beerepoot MA; ter Riet G; Nys S; van der Wal WM; de Borgie CA; de Reijke TM; Prins JM; Koeijers J; Verbon A; Stobberingh E; Geerlings SE
    Arch Intern Med; 2012 May; 172(9):704-12. PubMed ID: 22782199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotic and cranberry supplementation for preventing recurrent uncomplicated urinary tract infections in premenopausal women: a controlled pilot study.
    Koradia P; Kapadia S; Trivedi Y; Chanchu G; Harper A
    Expert Rev Anti Infect Ther; 2019 Sep; 17(9):733-740. PubMed ID: 31516055
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of Probiotics as Prophylaxis for Urinary Tract Infections in Premenopausal Women: A Systematic Review and Meta-Analysis.
    Abdullatif VA; Sur RL; Eshaghian E; Gaura KA; Goldman B; Panchatsharam PK; Williams NJ; Abbott JE
    Cureus; 2021 Oct; 13(10):e18843. PubMed ID: 34671514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review.
    Barrons R; Tassone D
    Clin Ther; 2008 Mar; 30(3):453-68. PubMed ID: 18405785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing the regulatory framework in South Africa - a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis.
    Happel AU; Singh R; Mitchev N; Mlisana K; Jaspan HB; Barnabas SL; Passmore JS
    BMC Infect Dis; 2020 Jul; 20(1):491. PubMed ID: 32650729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.
    Bradshaw CS; Pirotta M; De Guingand D; Hocking JS; Morton AN; Garland SM; Fehler G; Morrow A; Walker S; Vodstrcil LA; Fairley CK
    PLoS One; 2012; 7(4):e34540. PubMed ID: 22509319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.
    Raz R; Stamm WE
    N Engl J Med; 1993 Sep; 329(11):753-6. PubMed ID: 8350884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE).
    Allen SJ; Wareham K; Wang D; Bradley C; Sewell B; Hutchings H; Harris W; Dhar A; Brown H; Foden A; Gravenor MB; Mack D; Phillips CJ
    Health Technol Assess; 2013 Dec; 17(57):1-140. PubMed ID: 24309198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study.
    Larsson PG; Stray-Pedersen B; Ryttig KR; Larsen S
    BMC Womens Health; 2008 Jan; 8():3. PubMed ID: 18197974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women.
    Czaja CA; Stapleton AE; Yarova-Yarovaya Y; Stamm WE
    Infect Dis Obstet Gynecol; 2007; 2007():35387. PubMed ID: 18288237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Lactobacillus spp. to prevent recurrent urinary tract infections in females.
    Ng QX; Peters C; Venkatanarayanan N; Goh YY; Ho CYX; Yeo WS
    Med Hypotheses; 2018 May; 114():49-54. PubMed ID: 29602464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.